Hjem › Ewing-sarkom › Michigan
Ewing-sarkom kliniske forsøg i Michigan
8 studier for Ewing-sarkom søger deltagere på steder i Michigan.
Byer i Michigan
Officiel studietekst (engelsk)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Helen DeVos Children's Hospital, Grand Rapids
RekruttererFase 1
Alder 1 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07194044Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Corewell Health ( Site 1001), Grand Rapids
RekruttererFase 1/2
6 Months – 25 Years · Alle køn · Opdateret 17. sep. 2026 · NCT06395103Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- University of Michigan, Ann Arbor
- START Midwest Michigan, PC, Grand Rapids
RekruttererFase 1
Alder 12 til 85 · Alle køn · Opdateret 8. sep. 2026 · NCT03715933Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Hospital of Michigan/Wayne State University, Detroit
RekruttererFase 1/2
Op til 30 år · Alle køn · Opdateret 3. sep. 2026 · NCT06541262Lurbinectedin in FET-Fused Tumors
- University of Michigan, Ann Arbor
RekruttererFase 1/2
Alder 10 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT05918640Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- C S Mott Children's Hospital, Ann Arbor
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- William Beaumont University Hospital, Royal Oak
Rekrutterer
Alder 13 og opefter · Alle køn · Opdateret 6. feb. 2026 · NCT06387485Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Corewell Health, Grand Rapids
RekruttererFase 1/2
Alder 2 til 30 · Alle køn · Opdateret 3. feb. 2026 · NCT05734066Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.